Repeated Injections of Botulinum Toxin-A for Idiopathic Detrusor Overactivity

Urology

Volumn 75, Issue 3, 2010, Pages 552-558

  Sahai, Arun ^a   Dowson, Christopher ^a   Khan, Mohammad Shamim ^a   Dasgupta, Prokar ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BOTULINUM TOXIN A; CHOLINERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; BLADDER COMPLIANCE; BLADDER EMPTYING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTALGIA; CYSTOMETRY; CYSTOSCOPY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; IDIOPATHIC DETRUSOR OVERACTIVITY; MALE; MICTURITION DISORDER; ORCHITIS; OVERACTIVE BLADDER; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TREATMENT RESPONSE; URINARY TRACT INFECTION; URINE INCONTINENCE; URINE RETENTION; URODYNAMICS; UROSEPSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BOTULINUM TOXIN TYPE A; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INJECTIONS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PROSPECTIVE STUDIES; URINARY BLADDER, OVERACTIVE; YOUNG ADULT;

EID: 77649178590     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.05.097     Document Type: Article

References (18)

1. Apostolidis A., Dasgupta P., Denys P., et al. Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report. Eur Urol 55 (2009) 100-120
2. Brubaker L., Richter H.E., Visco A., et al. Refractory idiopathic urge urinary incontinence and botulinum A injection. J Urol 180 (2008) 217-222
3. Sahai A., Khan M.S., and Dasgupta P. Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial. J Urol 177 (2007) 2231-2236
4. Sahai A., Khan M.S., Le G.N., et al. Urodynamic assessment of poor responders after botulinum toxin-A treatment for overactive bladder. Urology 71 (2008) 455-459
5. Schafer W., Abrams P., Liao L., et al. Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 21 (2002) 261-274
6. Harper M., Popat R.B., Dasgupta R., et al. A minimally invasive technique for outpatient local anaesthetic administration of intradetrusor botulinum toxin in intractable detrusor overactivity. BJU Int 92 (2003) 325-326
7. Sahai A., Kalsi V., Khan M.S., et al. Techniques for the intradetrusor administration of botulinum toxin. BJU Int 97 (2006) 675-678
8. Khan S., Kessler T.M., Apostolidis A., et al. What a patient with refractory idiopathic detrusor overactivity should know about botulinum neurotoxin type A injection. J Urol 181 (2009) 1773-1778
9. Grosse J., Kramer G., and Stohrer M. Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol 47 (2005) 653-659
10. Karsenty G., Reitz A., Lindemann G., et al. Persistence of therapeutic effect after repeated injections of botulinum toxin type a to treat incontinence due to neurogenic detrusor overactivity. Urology 68 (2006) 1193-1197
11. Reitz A., Denys P., Fermanian C., et al. Do repeat intradetrusor botulinum toxin type a injections yield valuable results?. Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity. Eur Urol 52 (2007) 1729-1735
12. Del Popolo G., Filocamo M.T., Li M.V., et al. Neurogenic detrusor overactivity treated with English botulinum toxin a: 8-year experience of one single centre. Eur Urol 53 (2008) 1013-1020
13. Giannantoni A., Mearini E., Del Z.M., et al. Six-year follow-up of botulinum toxin A Intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results. Eur Urol 55 (2009) 705-712
14. Comperat E., Reitz A., Delcourt A., et al. Histologic features in the urinary bladder wall affected from neurogenic overactivity-a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type a. Eur Urol 50 (2006) 1058-1064
15. Critchfield J. Considering the immune response to botulinum toxin. Clin J Pain 18 suppl (2002) S133-S141
16. Schmid D.M., Sauermann P., Werner M., et al. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics. J Urol 176 (2006) 177-185
17. Sahai A., Sangster P., Kalsi V., et al. Assessment of urodynamic and detrusor contractility variables in patients with overactive bladder syndrome treated with botulinum toxin-A: is incomplete bladder emptying predictable?. BJU Int 103 (2009) 630-634
18. Kuo H.C. Will suburothelial injection of small dose of botulinum A toxin have similar therapeutic effects and less adverse events for refractory detrusor overactivity?. Urology 68 (2006) 993-997